Zobrazeno 1 - 10
of 50
pro vyhledávání: '"N. Pollicardo"'
Autor:
A. M. Carella, R. Ferrero, Francesco Frassoni, M. Soracco, N. Pollicardo, Ester Pungolino, Marina Podestà
Publikováno v:
Journal of Hematotherapy. 3:199-202
A group of 46 patients with chronic myelogenous leukemia (CML) [chronic phase (CP), 24 patients; accelerated phase (AP), 22 patients] ineligible for allogeneic bone marrow transplantation were given an intensive chemotherapy regimen consisting of ida
Autor:
M, Valbonesi, N, Pollicardo, P, Carlier, G, Florio, M R, Ruzzenenti, E, Pungolino, F, Benvenuto, O, Figari
Publikováno v:
Transfusion science. 17(4)
Peripheral blood stems cells (PBSCs) have been used in autologous transplantation as an alternative to bone marrow-derived cells. Recently, PBSCs have been collected from healthy donors after priming with G-CSF and used for allogeneic transplantation
Autor:
N. Pollicardo, M. Valbonesi
Publikováno v:
Transfusion science. 17(3)
Publikováno v:
The International journal of artificial organs. 19(7)
A new CFC apparatus for intraoperative blood salvage (CATS) has been introduced by Fresenius and submitted to preliminary evaluation at our hemapheresis unit. The volume of shed blood submitted to washing was 1714 ± 496 with a hematocrit of 19% and
Autor:
A M, Carella, F, Chimirri, M, Podestà, A, Pitto, G, Piaggio, A, Dejana, E, Lerma, N, Pollicardo, F, Vassallo, M, Soracco, F, Benvenuto, M, Valbonesi, P, Carlier, R, Vimercati, E, Prencipe, A M, Gatti, R A, Ferrara, M, Incagliato, G, Florio, F, Frassoni
Publikováno v:
Bone marrow transplantation. 17(2)
Twenty-three patients with chronic myelogenous leukemia in early chronic phase (ECP) and not previously treated with alpha-interferon (IFN-alpha) (10 patients), in ECP but pretreated with IFN-alpha (12 months) (seven patients) and in late chronic pha
Publikováno v:
Leukemia. 10(1)
The aims of this study were to analyze the characteristics and outcome of patients with secondary acute promyelocytic leukemia (APL) and compare them to those with primary APL. One hundred and thirteen patients referred to our service with a diagnosi
Autor:
M, Podestà, G, Piaggio, F, Frassoni, M, Sessarego, F, Benvenuto, O, Figari, A, Pitto, F, Vassallo, M, Soracco, N, Pollicardo
Publikováno v:
Bone marrow transplantation. 16(4)
We have previously demonstrated that Philadelphia negative (Ph-ve) hemopoietic cells can be collected by leukaphereses after an acute leukemia-like chemotherapy during the early hemopoietic recovery in patients with chronic myeloid leukemia (CML). In
Autor:
A M, Carella, N, Pollicardo, E, Pungolino, F, Frassoni, D, Giordano, R, Bruni, M, Spriano, E, Rossi
Publikováno v:
Leukemialymphoma. 15
Autor:
A M, Carella, F, Frassoni, N, Pollicardo, E, Pungolino, M, Podestà, D, Giordano, R, Ferrero, M, Soracco, F, Benvenuto, O, Figari
Publikováno v:
Bone marrow transplantation. 14
Autor:
A M, Carella, M, Podesta, F, Frassoni, M R, Raffo, N, Pollicardo, E, Pungolino, R, Vimercati, M, Sessarego, C, Parodi, C, Rabitti
Publikováno v:
Bone marrow transplantation. 12(3)
Twenty-five patients with CML (chronic phase (CP): 15 patients; accelerated phase (AP): 10 patients) at a median of 40 months after diagnosis and ineligible for allogeneic BMT, received an intensive chemotherapy regimen consisting of idarubicin, inte